All News

News: Factors Associated with COVID-19 Deaths in Rheumatic Patients https://t.co/FzsINtpZEz https://t.co/QzuLZRKaZy

Links:

Dr. John Cush RheumNow ( View Tweet)
healthcare.costs_.jpg

Congress Slams AbbVie Over Price Hikes, 'Frivolous' Patents

d MedPage Today

House lawmakers on both sides of the aisle pummeled AbbVie CEO Richard Gonzalez for raising the price of two widely used drugs and for the company's "legally questionable" tactics to head off competition from biosimilars, despite pulling in healthy profits.

Read Article
COVID.Flu_.Virus_.jpg (keep)

Factors Associated with COVID-19 Deaths in Rheumatic Patients

d Jack Cush, MD

Analysis of data from the COVID-19 Global Rheumatology Alliance shows that rheumatic diseases infected with COVID-19 had a greater risk of death with age, comorbidities, high disease activity and few specific therapies.

Read Article
#RNL2021: Difficult, Refractory RA Dr. Maya Buch presents Difficult, Refractory RA at RheumNow Live 2021. https://t.co/YG8gBFVCod

Links:

Dr. John Cush RheumNow ( View Tweet)

Listen to the latest RheumNow podcast--Myth Busters. Jack Cush discusses the latest rheum news on the site. Download wherever podcasts are available. https://t.co/q7FZTDo0BL https://t.co/fxGnyChzSO

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Podcast square

RheumNow Podcast – Myth Busters (5.21.2021)

d Jack Cush, MD

Dr Jack Cush reviews the news and journal reports from the past week on RheumNow.com

Read Article
RNL 2021: Pneumonia and RA - Dr. Jack Cush Did you miss #RNL2021? Our great panels are now available to watch on the site. https://t.co/1TR7fmdLq2

Links:

Dr. John Cush RheumNow ( View Tweet)

There is no downside to promoting oral health in our patients. Even without RCTs, knowing that there are possible links between oral health and RA outcomes is enough reason to have discussions with our patients with periodontal disease, and encourage treatment #EULARJC

Jon T Giles JonTGiles1 ( View Tweet)

If any rheums out there have not watched the vaccine town hall by @ACRheum I highly recommend it. A master class on vaccine counseling by @gradydoctor ! Thank you! Thanks @IreneBlancoMD and @DrDavidKarp https://t.co/4ofQVkjKYz via @YouTube

Links:

Jilaine Bolek Berquist BolekBerqui ( View Tweet)

colonperf.png

Tocilizumab Risk of Diverticulitis and GI Perforation

d Jack Cush, MD

A French registry analysis compared the risk of diverticulitis and gastrointestinal perforation (GIP) in rheumatoid arthritis (RA) patients treated with biologics and found a greater risk of both in patients receiving tocilizumab (TCZ) compared with those on rituximab (RTX) or abatacept (ABA

Read Article
TAA, TAR, Ankle, replacement

Total Ankle Arthroplasty vs. Arthodeisis?

d Jack Cush, MD

 The Journal of Bone & Joint Surgery reports the findings of a 4-year trial comparing outcomes of total ankle arthroplasty (TAA) versus ankle arthrodesis (AA) in patients with severe ankle arthritis; finding that while both groups improved, TAA was associated with less pain and better function after 4 years.

Read Article
Did you miss #RNL2021? We'll be sharing them on the site. RNL 2021: Interstitial Lung Disease in RA - Dr. Jeff Sparks ( @jeffsparks ) https://t.co/0Z5PsWyMFH

Links:

Dr. John Cush RheumNow ( View Tweet)

"Arthritis Mutilans" - worse outcome to chronic inflammatory arthritis is due to 5 disorders: 1) RA 2) Psoriatic arthritis 3) Tophaceous gout 4) polyarticular JIA 5) Multicentric reticulohistiocytosis (Ive never seen this!!) https://t.co/XYmBEW1F0R https://t.co/tGWNG9Aklw

Links:

Dr. John Cush RheumNow ( View Tweet)

"Arthritis Mutilans" - worse outcome to chronic inflammatory arthritis is due to 5 disorders: 1) RA 2) Psoriatic arthritis 3) Tophaceous gout 4) polyarticular JIA 5) Multicentric reticulohistiocytosis (Ive never seen this!!) https://t.co/XYmBEW1F0R https://t.co/tGWNG9Aklw

Links:

Dr. John Cush RheumNow ( View Tweet)

RNL, over, microphone

RheumNow Live 2021 Now Available for All

d Jack Cush, MD

RheumNow Live (RNL) for 2021 was held March 20 - 21 in Fort Worth, TX, and now all can partake in the meeting - by video, podcast or by signing up for Tuesday Nite Rheumatology (TNR).

Read Article
RNL 2021: EULAR 2019 and ACR 2020 RA Treatment Guidelines - Dr. Alan Matsumoto Dr. Alan Matsumoto presents EULAR 2019 and ACR 2020 RA Treatment Guidelines at the 2021 RheumNow Live meeting. https://t.co/1swZIWGWKc

Links:

Dr. John Cush RheumNow ( View Tweet)

Cerecor has launched a c Phase 1b clinical trial (NCT04752371) of the human mAb CERC-007, targeting IL-18, in 12 patients with active adult onset Still’s disease (AOSD). They estimate AOSD affects 3,500 - 7,000 in the US 3,400 - 6,900 pts in Europe https://t.co/DlW1QbXOG0

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: Risk Factors for Rheumatoid Arthritis-associated Interstitial Lung Disease https://t.co/ps8JeRUtJf https://t.co/Sn6ykG9ZuE

Links:

Dr. John Cush RheumNow ( View Tweet)
Sulfasalazine may be in short supply. FDA shortage lists shortage with drug return in July or 4th quarter of 2021. ASHP site also notes several generic maker shortages but they suggest resolution mid-May or July https://t.co/XYyraO6Z4z https://t.co/tm50S7ov9K https://t.co/QPWIitYkpp

Links:

Dr. John Cush RheumNow ( View Tweet)
Sulfasalazine may be in short supply. FDA shortage lists shortage with drug return in July or 4th quarter of 2021. ASHP site also notes several generic maker shortages but they suggest resolution mid-May or July https://t.co/XYyraO6Z4z https://t.co/tm50S7ov9K https://t.co/QPWIitYkpp

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright {{ 'now'|date('Y') }} All Rights Reserved.